Duloxetine Capsule, Delayed Release
Product Images NDC 72789-338

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Duloxetine (NDC 72789-338). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pd-rx Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (72789338)

FDA Label Image

Figure1 (Duloxetine Fig1)

FDA Label Image

Figure10 (Duloxetine Fig10)

Not available.*

FDA Label Image

Figure2 (Duloxetine Fig2)

The text suggests a graph showing the proportion of patients with relapse over time. The graph includes two treatment groups, which are labeled as "Placebo" and "DULOXETINE." The x-axis represents the time from randomization to relapse in days, while the y-axis shows the proportion of patients with relapse. The graph appears to span a period of 300 days, with data points at different time intervals.*

FDA Label Image

Figure3 (Duloxetine Fig3)

FDA Label Image

Figure4 (Duloxetine Fig4)

FDA Label Image

Figure5 (Duloxetine Fig5)

FDA Label Image

Figure6 (Duloxetine Fig6)

FDA Label Image

Figure8 (Duloxetine Fig8)

FDA Label Image

Figure9 (Duloxetine Fig9)

FDA Label Image

Structure (Duloxetine Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.